Scion Asset Management's Top Q2 Moves: New Positions in Lululemon, Regeneron, and UnitedHealth
ByAinvest
Friday, Aug 15, 2025 11:11 am ET1min read
LULU--
In its latest 13F filing, Scion reported holding 50,000 shares in Lululemon, 15,000 shares in Regeneron, and 20,000 shares in UnitedHealth. The fund also decreased its stake in Estée Lauder (EL) to 150,000 shares from 200,000 shares. Additionally, Scion initiated new positions in MercadoLibre (MELI) and Bruker (BRKR) [1].
Michael Burry's investment strategy is known for its long-term focus and thorough research. His new positions in consumer and healthcare sectors suggest a bullish outlook on these industries. Lululemon, a leading athletic apparel brand, has shown strong growth in recent years, driven by its focus on wellness and active lifestyles. Regeneron, a biotechnology company, is at the forefront of innovation in healthcare, particularly in the areas of genomics and immunology. UnitedHealth Group, a diversified healthcare company, has a strong presence in managed care and healthcare services.
The Q2 moves by Scion Asset Management are part of a broader trend in the investment community. Other notable Q2 moves include Bridgewater Associates adding ARM Holdings and exiting Alibaba, Jana Partners exiting Fidelity National Information and adding Wex, Soros Capital betting on South Korea and South Korea chips while withdrawing from Brazil, and Philippe Laffont's Coatue taking a new stake in Oracle and exiting Super Micro [1].
Investors and financial professionals should closely monitor these developments to understand the broader market sentiment and potential opportunities. Scion's new positions could provide insights into the fund's strategy and the sectors it views as attractive for future growth.
References:
[1] https://seekingalpha.com/news/4485767-michael-burrys-scion-starts-new-position-in-unitedhealth-lululemon-and-regeneron-among-top-q2-moves
REGN--
UNH--
Scion Asset Management, founded by Michael Burry, has disclosed its Q2 moves, including starting new positions in lululemon athletica, Regeneron Pharmaceuticals, and UnitedHealth Group. The fund's other top Q2 moves are not specified in the article.
Scion Asset Management, founded by Michael Burry, has disclosed its Q2 2025 moves, including new positions in lululemon athletica (LULU), Regeneron Pharmaceuticals (REGN), and UnitedHealth Group (UNH). The fund's other top Q2 moves are not specified in the article.In its latest 13F filing, Scion reported holding 50,000 shares in Lululemon, 15,000 shares in Regeneron, and 20,000 shares in UnitedHealth. The fund also decreased its stake in Estée Lauder (EL) to 150,000 shares from 200,000 shares. Additionally, Scion initiated new positions in MercadoLibre (MELI) and Bruker (BRKR) [1].
Michael Burry's investment strategy is known for its long-term focus and thorough research. His new positions in consumer and healthcare sectors suggest a bullish outlook on these industries. Lululemon, a leading athletic apparel brand, has shown strong growth in recent years, driven by its focus on wellness and active lifestyles. Regeneron, a biotechnology company, is at the forefront of innovation in healthcare, particularly in the areas of genomics and immunology. UnitedHealth Group, a diversified healthcare company, has a strong presence in managed care and healthcare services.
The Q2 moves by Scion Asset Management are part of a broader trend in the investment community. Other notable Q2 moves include Bridgewater Associates adding ARM Holdings and exiting Alibaba, Jana Partners exiting Fidelity National Information and adding Wex, Soros Capital betting on South Korea and South Korea chips while withdrawing from Brazil, and Philippe Laffont's Coatue taking a new stake in Oracle and exiting Super Micro [1].
Investors and financial professionals should closely monitor these developments to understand the broader market sentiment and potential opportunities. Scion's new positions could provide insights into the fund's strategy and the sectors it views as attractive for future growth.
References:
[1] https://seekingalpha.com/news/4485767-michael-burrys-scion-starts-new-position-in-unitedhealth-lululemon-and-regeneron-among-top-q2-moves

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet